<html>
<head>PUBMED IDs for BCAR3</head>
<body bgcolor='#C5F0F2'><h1>BCAR3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9582273/'>Identification of BCAR3 by a random search for genes involved in antiestrogen resistance of human breast cancer cells.</a> June 10  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/11027651/'>Altered gene expression upon BCR cross-linking in Burkitt's lymphoma B cell line.</a> October 12  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/14583477/'>AND-34/BCAR3, a GDP exchange factor whose overexpression confers antiestrogen resistance, activates Rac, PAK1, and the cyclin D1 promoter.</a> October 30  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14654988/'>Identification and characterization of human FNBP1L gene in silico.</a> December 5  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/16740993/'>CrkII associates with BCAR3 in response to endothelin-1 in human glomerular mesangial cells.</a> June 3  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17270363/'>Splice variants and expression patterns of SHEP1, BCAR3 and NSP1, a gene family involved in integrin and receptor tyrosine kinase signaling.</a> February 3  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17427198/'>AND-34/BCAR3 differs from other NSP homologs in induction of anti-estrogen resistance, cyclin D1 promoter activation and altered breast cancer cell morphology.</a> April 12  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17616674/'>Breast cancer antiestrogen resistance-3 expression regulates breast cancer cell migration through promotion of p130Cas membrane localization and membrane ruffling.</a> July 10  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18351453/'>Functional identification of genes causing estrogen independence of human breast cancer cells.</a> March 21  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19086031/'>Pyk2 mediates endothelin-1 signaling via p130Cas/BCAR3 cascade and regulates human glomerular mesangial cell adhesion and spreading.</a> February 28  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19454314/'>AND-34/BCAR3 regulates adhesion-dependent p130Cas serine phosphorylation and breast cancer cell growth pattern.</a> August 15  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19454287/'>Convergence of Wnt signaling on the HNF4alpha-driven transcription in controlling liver zonation.</a> August 14  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19454286/'>Elevated Dnmt3a activity promotes polyposis in Apc(Min) mice by relaxing extracellular restraints on Wnt signaling.</a> September 16  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19454285/'>Analysis of HLA and non-HLA alleles can identify individuals at high risk for celiac disease.</a> September 16  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20603213/'>The SH2 domain protein Shep1 regulates the in vivo signaling function of the scaffolding protein Cas.</a> December 22  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21262352/'>BCAR3/AND-34 can signal independent of complex formation with CAS family members or the presence of p130Cas.</a> June 28  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22328489/'>Protein pathway activation mapping reveals molecular networks associated with antiestrogen resistance in breast cancer cell lines.</a> November 9  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23762409/'>Breast cancer antiestrogen resistance 3 (BCAR3) promotes cell motility by regulating actin cytoskeletal and adhesion remodeling in invasive breast cancer cells.</a> January 15  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24553122/'>Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile.</a> May 10  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24584939/'>Association of the breast cancer antiestrogen resistance protein 1 (BCAR1) and BCAR3 scaffolding proteins in cell signaling and antiestrogen resistance.</a> June 21  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25081647/'>Evaluation of the ability of adjuvant tamoxifen-benefit gene signatures to predict outcome of hormone-naive estrogen receptor-positive breast cancer patients treated with tamoxifen in the advanced setting.</a> August 20  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/28458685/'>Fatty Acids of CLA-Enriched Egg Yolks Can Induce Transcriptional Activation of Peroxisome Proliferator-Activated Receptors in MCF-7 Breast Cancer Cells.</a> May 2  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28458671/'>Anti-Apolipoprotein A-1 IgG Predict All-Cause Mortality and Are Associated with Fc Receptor-Like 3 Polymorphisms.</a> May 2  2017<br></body></html>
